Frequent recalls made by drug companies have raised concerns among people who take medicines regularly. Another blood pressure medication has been recalled over concerns that it can contain a few traces of carcinogens. The information has been given by U.S Food and Drug Administration which said that Macleods Pharmaceuticals Limited has voluntarily recalled one lot of the Losartan Potassium/Hydrochlorothiazide combination tablets due to detection of trace amounts of an unexpected impurity.
The agency on its website wrote, “The impurity detected is N-nitrosodiethylamine (NDEA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification”. The new drug has been added to the list of blood pressure medications that have been recalled since October 2018.
The FDA has also informed that it has been packed in bottles and can be identified by checking the product name, manufacturer details and batch or lot number on the bottle. Talking about the medication, Macloeds Pharmaceuticals Limited has so far not received any reports of adverse events related to this recall.
The company is making arrangements for return of all recalled products to Qualanex. In case the product customers want more information they can contact Qualanex through email at recall@qualanex.com or call on 888 280 2042. As a safety measure, the FDA has also advised the consumers to contact their healthcare provider if they have experienced any problems that may be related to taking or using the drug.
Photo Credits: Pixabay
